Physician profile
Milad Adloo
NPI 1619596269
$4,399.46
in general payments reported to CMS, 2019-2025
13 companies · $747 in 2025
The $747 reported for 2025 was more than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $22.02 · 2023: $1,341 · 2024: $2,289 · 2025: $747.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $2,274 · Food and Beverage: $2,103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $2,274.31 |
| Food and Beverage | $2,103.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,414.14 | 2024 | |
| Kci USA, INC. | $1,218.63 | 2023 | Prevena, Tegaderm, 3m Cavilon |
| Treace Medical Concepts, INC. | $700.06 | 2024-2025 | |
| Stryker Corporation | $387.13 | 2025 | Limflow System, Augment Injectable, Citrefix |
| Depuy Synthes Sales INC. | $262.66 | 2024-2025 | Motoband, Hammerlock |
| Linvatec Corporation | $122.66 | 2023 | Colink Plating System, Biobrace 23mm |
| Suvon Surgical LLC | $72.29 | 2024 | |
| Smith+Nephew, INC. | $65.63 | 2022-2025 | Grafix Pl, Collagenase Santyl |
| Orthofix Medical, INC. | $39.59 | 2024 | Physio-Stim, Accelstim |
| Mimedx Group, INC. | $34.63 | 2024 | |
| Merck Sharp & Dohme LLC | $34.60 | 2025 | Pifeltro |
| Viiv Healthcare Company | $23.80 | 2025 | Apretude |
| Lifenet Health | $23.64 | 2025 | Theragenesis Wound Matrix |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Milad Adloo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.